Authors
Latest:
Overview of Nurtec ODT for Prevention of Episodic MigraineNurtec is the first oral calcitonin gene-related peptide antagonist approved for both acute and preventative treatment of migraine.
Latest:
The Role of Pharmacists in HIV Care Continues to ExpandPharmacists play a vital role in HIV care by addressing social determinants of health, managing complex HIV medication regimens, and providing comprehensive patient counseling.
Latest:
The Perfect Ingredient: Vaccine Education With Pharmacy Community Health WorkersIn Missouri, community health workers partnered with community pharmacists, CPESN, and others to develop a state-funded program to address vaccine gaps in local communities.
Latest:
Providing Food Security From Across the Pharmacy CounterPharmacists can play a critical role in addressing food insecurity in their communities, with a variety of tools at their disposal.
Latest:
Lower Discontinuation Rates on Cycled Oral Antineoplastics Can Lead to Lower Medical Costs, Fewer HospitalizationsThese agents are likely to become the mainstay of cancer treatment in the very near future.
Latest:
CDC and FDA Recommendations for SARS-CoV-2 Booster ShotsExperts in the management of SARS-CoV-2 educate on CDC and FDA recommendations for approaching administration of booster vaccines, including those for special patient populations.
Latest:
Evaluation of Factors Driving Rheumatoid Arthritis Moderate to High Disease Activity on Routine Assessment of Patient Index Data 3 ScoreUtilization of the RAPID3 tool can be a beneficial way for pharmacists to complete disease activity assessments without physically seeing the patient in a clinic setting.
Latest:
Managing Blood Glucose Levels for Expectant Mothers With DiabetesCGM enhances diabetes management in pregnancy, improving outcomes.
Latest:
Impact of PD-1 and PD-L1 Expression on Overall Survival in Patients With NSCLC and MelanomaPharmacists play a vital role in therapy selection.
Latest:
Data Analytics Help Specialty Pharmacies Personalize Health CareAdvanced analytics will continue to make health care more accessible and empower pharmacists with the ability to personalize treatments.
Latest:
How I Overcame My Battle With Autoimmune Disease to Become a PharmacistAlthough it is critical that we listen to every patient we treat, it's also important to listen to the needs of our bodies first, as this will allow us to better care for others.
Latest:
Gepotidacin Receives FDA Priority Review for the Treatment of Uncomplicated Urinary Tract InfectionsGepotidacin could be first-in-class oral antibiotic treatment approved for uUTIs in over 20 years.
Latest:
What is Needed to Turn the COVID-19 Pandemic into an EndemicFor COVID-19 to turn into an endemic, there are a few criteria that must be met.
Latest:
Clinical Overview: Oral Diabetes Medications in ChildrenDespite the surge in new diabetes cases, the treatment options in in children remain limited.
Latest:
Medically Integrated Pharmacies, Oral Oncolytic Agents Grow in Importance During COVID-19As practices have gained experience in the post-COVID-19 environment, health care professionals have found innovative ways to work around many of the obstacles the pandemic presents.
Latest:
Technology Can Help Ease Provider Burnout, Access to Health CareThe need for pharmacists to return to a more clinically-focused role became apparent as the COVID-19 pandemic revealed gaps in patient access to care across the country.
Latest:
With DSCSA Compliance Delay, Certain Requirements Still Require Action NowLaunching development of SOPs and communication with wholesalers is key.
Latest:
Managing Treatment With New and Expensive Drugs: What Pharmacy Leaders Need to KnowWith the introduction of expensive drugs and associated challenges for hospital budgets, pharmacy leaders benefit from strategically managing financial, clinical, and regulatory factors for sustainable care delivery.
Latest:
California Modifies End of Life Option ActAmendments reflecting more contemporary options could raise ethical questions for health care workers.
Latest:
Once-Weekly Insulin Analogue Demonstrates Promising Results for Those With Type 2 DiabetesPatients with type 2 diabetes receiving once-weekly insulin icodec were more likely to reach a hemoglobin A1C level below 7% compared to those who received once-daily insulin analogues.
